Treace Medical Concepts, Inc. (NasdaqGS: TMCI)
Health Care · Health Care Equipment & Supplies · US
$4.07
+2.91% today · -34.2% 1Y
Treace Medical Concepts, Inc. (NasdaqGS: TMCI) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $256.89M and employs 450 people.
Over the last twelve months the share price has lost 34.2%, trading between 1.17 and 7.08.
Tweenvest scores Treace Medical Concepts, Inc. across four factors: quality 55/100, value 65/100, growth 100/100. Its strongest factor is growth.
TMCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $256.89M
- Revenue (TTM)
- $205.31M
- P/E
- —
- EPS
- -0.93
- Dividend yield
- —
- Beta (5Y)
- 1.49
- 52-week high
- $7.08
- 52-week low
- $1.17
- Avg volume (3M)
- —
- Shares outstanding
- 65.03M
- Employees
- 450
- Next earnings
- —
About Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
- ISIN
- US89455T1097
- Founded
- 2013
- Listed since
- Apr 23, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tristel plcAIM: TSTL | $275.14M | £4.35 | +0.58% |
| Surgical Science Sweden AB (publ)OM: SUS | $272.50M | Skr55.30 | +3.56% |
| OraSure Technologies, Inc.NasdaqGS: OSUR | $268.98M | $3.93 | +0.77% |
| Suzhou Iron Technology CO.,LTDSHSE: 688329 | $261.76M | CN¥23.43 | -2.17% |
| United Orthopedic CorporationTPEX: 4129 | $252.44M | NT$83.70 | +1.70% |
| Profound Medical Corp.TSX: PRN | $251.69M | CA$9.83 | +17.58% |
| Dentium CO., LTDKOSE: A145720 | $248.06M | ₩40,350.00 | +4.13% |
| Medikit Co.,Ltd.TSE: 7749 | $246.05M | ¥2,691.00 | -1.61% |
Figures last refreshed Oct 11, 2026.